Jung‐Yu Kan

742 total citations
29 papers, 561 citations indexed

About

Jung‐Yu Kan is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Jung‐Yu Kan has authored 29 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 12 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Jung‐Yu Kan's work include Cancer, Lipids, and Metabolism (5 papers), Immunotherapy and Immune Responses (3 papers) and Cancer-related molecular mechanisms research (3 papers). Jung‐Yu Kan is often cited by papers focused on Cancer, Lipids, and Metabolism (5 papers), Immunotherapy and Immune Responses (3 papers) and Cancer-related molecular mechanisms research (3 papers). Jung‐Yu Kan collaborates with scholars based in Taiwan, China and United States. Jung‐Yu Kan's co-authors include Po‐Lin Kuo, Ming‐Feng Hou, Meng‐Chi Yen, Ya‐Ling Hsu, Jaw‐Yuan Wang, Deng‐Chyang Wu, Ya‐Wen Ho, Fu Ou‐Yang, Tun‐Chieh Chen and Jen‐Yu Hung and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Journal of Cellular Physiology.

In The Last Decade

Jung‐Yu Kan

29 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jung‐Yu Kan Taiwan 15 341 226 138 74 60 29 561
Wuguo Li China 16 569 1.7× 272 1.2× 192 1.4× 78 1.1× 85 1.4× 31 842
Xiuling Li China 14 228 0.7× 145 0.6× 108 0.8× 82 1.1× 48 0.8× 29 468
Olga Surova Sweden 11 404 1.2× 163 0.7× 118 0.9× 43 0.6× 47 0.8× 17 564
Saeed Noorolyai Iran 11 451 1.3× 225 1.0× 171 1.2× 69 0.9× 102 1.7× 24 708
Kaiyuan Hui China 12 276 0.8× 152 0.7× 183 1.3× 84 1.1× 74 1.2× 33 537
Francesco Caiazza Ireland 12 295 0.9× 157 0.7× 278 2.0× 77 1.0× 74 1.2× 24 672
Zhimin Fan China 15 319 0.9× 181 0.8× 140 1.0× 106 1.4× 81 1.4× 32 566
Gao Liu China 14 470 1.4× 388 1.7× 133 1.0× 41 0.6× 156 2.6× 35 833
Daniel Doheny United States 12 363 1.1× 151 0.7× 265 1.9× 103 1.4× 85 1.4× 16 681

Countries citing papers authored by Jung‐Yu Kan

Since Specialization
Citations

This map shows the geographic impact of Jung‐Yu Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung‐Yu Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung‐Yu Kan more than expected).

Fields of papers citing papers by Jung‐Yu Kan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jung‐Yu Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung‐Yu Kan. The network helps show where Jung‐Yu Kan may publish in the future.

Co-authorship network of co-authors of Jung‐Yu Kan

This figure shows the co-authorship network connecting the top 25 collaborators of Jung‐Yu Kan. A scholar is included among the top collaborators of Jung‐Yu Kan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jung‐Yu Kan. Jung‐Yu Kan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kan, Jung‐Yu, Ming‐Feng Hou, Hung‐Pei Tsai, et al.. (2024). Metabolic shifts in lipid utilization and reciprocal interactions within the lung metastatic niche of triple-negative breast cancer revealed by spatial multi-omics. Cell Death and Disease. 15(12). 899–899. 4 indexed citations
2.
Kan, Jung‐Yu, Sheau‐Fang Yang, Pei‐Yi Chu, et al.. (2024). Exosomal microRNA-92b Is a Diagnostic Biomarker in Breast Cancer and Targets Survival-Related MTSS1L to Promote Tumorigenesis. International Journal of Molecular Sciences. 25(2). 1295–1295. 14 indexed citations
3.
Kan, Jung‐Yu, et al.. (2023). Correlation of Beta2-Glycoprotein I With Tumor Prognosis in Breast Cancer Patients. Anticancer Research. 43(8). 3455–3462. 2 indexed citations
4.
Moi, Sin‐Hua, Ming‐Feng Hou, Fang‐Ming Chen, et al.. (2022). Comprehensive Transcriptomic and Proteomic Analyses Identify a Candidate Gene Set in Cross-Resistance for Endocrine Therapy in Breast Cancer. International Journal of Molecular Sciences. 23(18). 10539–10539. 1 indexed citations
5.
Hou, Ming‐Feng, Fu Ou‐Yang, Fang‐Ming Chen, et al.. (2021). Comprehensive profiles and diagnostic value of menopausal-specific gut microbiota in premenopausal breast cancer. Experimental & Molecular Medicine. 53(10). 1636–1646. 39 indexed citations
6.
Hsieh, Tsung‐Hua, Chia‐Yi Hsu, Chien‐Chih Chiu, et al.. (2021). DEHP mediates drug resistance by directly targeting AhR in human breast cancer. Biomedicine & Pharmacotherapy. 145. 112400–112400. 32 indexed citations
8.
Kan, Jung‐Yu, Sin‐Hua Moi, Wen‐Chun Hung, et al.. (2020). Comprehensive Transcriptomic Analysis Identifies ST8SIA1 as a Survival-Related Sialyltransferase Gene in Breast Cancer. Genes. 11(12). 1436–1436. 14 indexed citations
9.
Ou‐Yang, Fu, et al.. (2020). Activation of mitochondrial unfolded protein response is associated with Her2-overexpression breast cancer. Breast Cancer Research and Treatment. 183(1). 61–70. 22 indexed citations
10.
Kan, Jung‐Yu, et al.. (2020). Cost-effectiveness of stereotactic vacuum-assisted biopsy for nonpalpable breast lesions. European Journal of Radiology. 127. 108982–108982. 5 indexed citations
11.
Yen, Meng‐Chi, et al.. (2019). New Insight on Solute Carrier Family 27 Member 6 (SLC27A6) in Tumoral and Non-Tumoral Breast Cells. International Journal of Medical Sciences. 16(3). 366–375. 27 indexed citations
12.
Ou‐Yang, Fu, et al.. (2019). Accuracy and outcomes of stereotactic vacuum‐assisted breast biopsy for diagnosis and management of nonpalpable breast lesions. The Kaohsiung Journal of Medical Sciences. 35(10). 640–645. 9 indexed citations
13.
Yen, Meng‐Chi, et al.. (2018). Solute Carrier Family 27 Member 4 (SLC27A4) Enhances Cell Growth, Migration, and Invasion in Breast Cancer Cells. International Journal of Molecular Sciences. 19(11). 3434–3434. 38 indexed citations
14.
Yen, Meng‐Chi, Jung‐Yu Kan, Chia‐Jung Hsieh, et al.. (2017). Association of long-chain acyl-coenzyme A synthetase 5 expression in human breast cancer by estrogen receptor status and its clinical significance. Oncology Reports. 37(6). 3253–3260. 40 indexed citations
15.
Kan, Jung‐Yu, Meng‐Chi Yen, Jaw‐Yuan Wang, et al.. (2016). Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer. Oncotarget. 7(21). 31336–31349. 66 indexed citations
16.
Huang, Chih–Jen, Ming‐Feng Hou, Jung‐Yu Kan, et al.. (2015). Prophylactic Treatment with Adlay Bran Extract Reduces the Risk of Severe Acute Radiation Dermatitis: A Prospective, Randomized, Double-Blind Study. Evidence-based Complementary and Alternative Medicine. 2015. 1–8. 17 indexed citations
17.
Tsai, Ying‐Ming, Ya‐Ling Hsu, Ming‐Feng Hou, et al.. (2014). Cluster of differentiation 45 activation is crucial in interleukin-10-dependent tumor-associated dendritic cell differentiation. Oncology Letters. 8(2). 620–626. 3 indexed citations
18.
Huang, Meng-Lin, Jung‐Yu Kan, Cheng‐Jen Ma, et al.. (2012). An observational study of bevacizumab combined with FOLFIRI as the first-line treatment in metastatic colorectal cancer. 4(4). 122–127. 1 indexed citations
19.
Kan, Jung‐Yu, Jan‐Sing Hsieh, Wen‐Ming Wang, et al.. (2006). Clinical Characteristics of Patients with Sporadic Colorectal Cancer and Primary Cancers of Other Organs. The Kaohsiung Journal of Medical Sciences. 22(11). 547–553. 12 indexed citations
20.
Kan, Jung‐Yu, et al.. (2005). Laparoscopy-Assisted Management of Jejunal Bezoar Obstruction. Surgical Laparoscopy Endoscopy & Percutaneous Techniques. 15(5). 297–298. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026